Status:
COMPLETED
Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study
Lead Sponsor:
Sun Yat-sen University
Conditions:
Retinoblastoma
Eligibility:
All Genders
1-20 years
Phase:
NA
Brief Summary
To study the effectiveness and safety profiles of photodynamic therapy (PDT) for the treatment of human retinoblastoma.
Detailed Description
Retinoblastoma is the commonest primary intraocular malignancy in infancy and early childhood. Ophthalmologist are trying to seek other more safe and effective treatment modalities to well control the...
Eligibility Criteria
Inclusion
- patients with intraocular retinoblastoma of Group A-D
Exclusion
- (1) patients with intraocular retinoblastoma of group E; (2) patients with extraocular spread; (3); media opacities such as corneal opacity, significant cataract, or vitreous hemorrhage obscuring fundus examination; (4) patients who were allergic to verteporfin or other benzoporphyrin derivatives.
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04429139
Start Date
February 1 2011
End Date
May 30 2020
Last Update
June 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kunbei Lai
Guangzhou, Guangdong, China, 510000